Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2003

01-04-2003 | Review

Breast cancer cell lines: friend or foe?

Authors: Sarah E Burdall, Andrew M Hanby, Mark RJ Lansdown, Valerie Speirs

Published in: Breast Cancer Research | Issue 2/2003

Login to get access

Abstract

The majority of breast cancer research is conducted using established breast cancer cell lines as in vitro models. An alternative is to use cultures established from primary breast tumours. Here, we discuss the pros and cons of using both of these models in translational breast cancer research.
Literature
1.
Osborne CK, Hobbs K, Trent JM: Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res Treat. 1987, 9: 111-121.CrossRefPubMed
2.
Bahia H, Ashman JNE, Cawkwell L, Lind M, Monson JRT, Drew PJ, Greenman J: Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization. Int J Oncol. 2002, 20: 489-494.PubMed
3.
Nelson-Rees WA, Daniels DW, Flandermeyer RR: Cross-contamination of cells in culture. Science. 1981, 212: 446-452.CrossRefPubMed
4.
Gey GO, Coffman WD, Kubicek MT: Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 1952, 12: 264-265.
5.
MacLeod RAF, Dirks WG, Matsui Y, Kaufmannn M, Milch H, Drexler HG: Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer. 1999, 83: 555-563. 10.1002/(SICI)1097-0215(19991112)83:4<555::AID-IJC19>3.0.CO;2-2.CrossRefPubMed
6.
Masters JRW: Human cancer cell lines: fact and fantasy. Nat Rev Mol Biol. 2000, 1: 233-236. 10.1038/35043102.CrossRef
7.
Masters JRW, Thomson JA, Daly-Burns B, Reid YA, Dirks WG, Packer P, Toji LH, Ohno T, Tanabe H, Arlett CF, Kelland LR, Harrison M, Virmani A, Ward TH, Ayres KL, Debenham PG: Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci USA. 2001, 98: 8012-8017. 10.1073/pnas.121616198.CrossRefPubMedPubMedCentral
8.
Soule HD, Vasquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst. 1973, 51: 1409-1413.PubMed
9.
Ozzello L, Sordat B, Merenda C, Carrel S, Hurlimann J, Mach JP: Transplantation of a human mammary carcinoma cell line (BT 20) into nude mice. J Natl Cancer Inst. 1974, 52: 1669-1672.PubMed
10.
Cailleau R, Young R, Olive M, Reeves WJ: Breast tumour cell lines from pleural effusions. J Natl Cancer Inst. 1974, 53: 661-674.PubMed
11.
Cailleau R, Olive M, Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro. 1978, 14: 911-915.CrossRefPubMed
12.
Trempe GL: Human breast cancer in culture. Recent Results Cancer Res. 1976, 57: 33-41.
13.
Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ: Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer. 1979, 15: 659-370. 10.1016/0014-2964(79)90139-7.CrossRefPubMed
14.
Engel LW, Young NA, Tralka TS, Lippman ME, O'Brien SJ, Joyce MB: Establishment and characterization of three new continuous cell lines derived from human breast carcinomas. Cancer Res. 1978, 38: 3352-3364.PubMed
15.
Ethier SP, Mahacek ML, Gullick WJ, Frank Tja ND, Weber BL: Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 1993, 53: 627-635.PubMed
16.
McCallum HM, Lowther GW: Long term culture of primary breast cancer in defined medium. Breast Cancer Res Treat. 1996, 39: 247-259.CrossRefPubMed
17.
Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, Kodagoda D, Stasny V, Cunningham HT, Wistuba II, Tomlinson G, Tonk V, Ashfaq R, Leitch AM, Minna JD, Shay JW: Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int J Cancer. 1998, 78: 766-774. 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L.CrossRefPubMed
18.
Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmandian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AF: Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res. 1998, 4: 23931-2938.
19.
Freshney RI: Introduction to basic principles. In Animal Cell Culture: a Practical Approach. Edited by: Freshney RI. 1992, Oxford: IRL Press, 1-14.
20.
Forozan F, Mahlamaki EH, Monni O, Chen Y, Veldman R, Jiang Y, Gooden C, Ethier SP, Kallioiemi A, Kallioniemi O: Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000, 60: 4519-4525.PubMed
21.
Ethier SP, Kokeney KE, Ridings JW, Dilts CA: erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res. 1996, 56: 899-907.PubMed
22.
Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer. 1998, 21: 177-184. 10.1002/(SICI)1098-2264(199803)21:3<177::AID-GCC1>3.0.CO;2-X.CrossRefPubMed
23.
Forozan F, Veldman R, Ammerman CA, Parsa NZ, Kallioniemi A, Kallioniemi OP, Ethier SP: Molecular cytogenetic analysis of 11 new breast cancer cell lines. Br J Cancer. 1999, 81: 1328-1334. 10.1038/sj.bjc.6695007.CrossRefPubMedPubMedCentral
24.
Freshney RI: Induction of differentiation in neoplastic cells. Anticancer Res. 1985, 5: 111-130.PubMed
25.
Lasfargues EY, Ozzello L: Cultivation of human breast carcinomas. J Natl Cancer Inst. 1958, 21: 1131-1147.PubMed
26.
Dairkee SH, Deng G, Stampfer MR, Waldman FM, Smith HS: Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumour cells. Cancer Res. 1997, 57: 1590-1596.PubMed
27.
Dairkee SH, Deng G, Stampfer MR, Waldman F, Smith HS: Selective culture of primary breast carcinoma. Cancer Res. 1995, 55: 2516-2519.PubMed
28.
Speirs V, Green AR, White MC: Collagenase III: a superior enzyme for complete disaggregation and improved viability of normal and malignant human breast tissue. In Vitro Cell Devel Biol. 1996, 32: 72-74.CrossRef
29.
Emerman JT, Wilkinson DA: Routine culturing of normal, dysplastic and malignant human mammary epithelial cells from small tissue samples. In Vitro Cell Develop Biol. 1990, 26: 1186-1194.CrossRef
30.
Speirs V, Green AR, Walton DS, Kerin MJ, Fox JN, Carleton PJ, Desai SB, Atkin SL: Short-term primary culture of epithelial cells derived from human breast tumours. Br J Cancer. 1998, 78: 1421-1429.CrossRefPubMedPubMedCentral
31.
Speirs V, Green AR, Atkin SL: Activity and expression of 17β-hydroxysteroid dehydrogenase type I in primary cultures of epithelial and stromal cells derived from normal and tumourous human breast tissue: the role of IL-8. J Steroid Biochem Molec Biol. 1998, 67: 267-274. 10.1016/S0960-0760(98)00119-8.CrossRefPubMed
32.
Loveday RL, Speirs V, Drew PJ, Kerin MJ, Monson JR, Greenman J: Intracellular flow cytometric analysis of primary cultured breast tumour cells. Cancer Invest. 2002, 20: 340-347. 10.1081/CNV-120001179.CrossRefPubMed
33.
Wolman SR, Mohamed AN, Heppner GH, Soule HD: Chromosomal markers of immortalization in human breast epithelium. Genes Chromosomes Cancer. 1994, 10: 59-65.CrossRefPubMed
34.
Clarke C, Titley J, Davies S, O'Hare MJ: An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. Epithelial Cell Biol. 1994, 3: 38-46.PubMed
35.
Gudjonsson T, Villadsen R, Nielsen HK, Ronnov-Jessen , Bissell MJ, Petersen OW: Isolation, immortalisation, and characterisation of a human breast epithelial cell line with stem cell properties. Genes Devel. 2002, 16: 693-706. 10.1101/gad.952602.CrossRefPubMedPubMedCentral
36.
Taylor-Papadimitrou J, Stampfer MS, Bartek J, Lewis A, Boshell M, Lane EB, Leigh IM: Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci. 1989, 94: 403-413.
37.
Ethier SP: Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia. 1996, 1: 111-121.CrossRefPubMed
38.
Imam SA, Kim MS, Anker L, Data RH, Law RE, Taylor CR: Systematic determination of telomerase activity and telomerase length during the progression of human breast cancer in cell culture models. Anticancer Res. 1997, 17: 4435-4441.PubMed
39.
Hood CJ, Parham DM: A simple method of tumour culture. Pathol Res Practice. 1998, 194: 177-181.CrossRef
40.
Biran S, Vlodavsky I, Fuks Z, Lijovetzky G, Horowitz AT: Growth of human mammary carcinoma cells from biopsy specimens in serum-free medium on extracellular matrix. Int J Cancer. 1986, 38: 345-354.CrossRefPubMed
41.
Bergstraesser LM, Weitzman SA: Culture of normal and malignant primary human mammary epithelial cells in a physiological manner simulates in vivo growth patterns and allows discrimination of cell type. Cancer Res. 1993, 53: 2644-2654.PubMed
42.
Ip MM, Darcy KM: Three-dimensional mammary primary culture model systems. J Mammary Gland Biol Neoplasia. 1996, 1: 91-110.CrossRefPubMed
43.
Krasna L, Dudorkinova D, Vedralova J, Vesely P, Pokorna E, Kudlackova I, Chaloupkova A, Petruzelka L, Danes J, Matouskova E: Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours. Breast Cancer Res Treat. 2002, 71: 219-235. 10.1023/A:1014457731494.CrossRefPubMed
44.
45.
Li Z, Bustos V, Miner j, Paulo E, Meng ZH, Zlotnikov G, Ljung B-M, Dairkee S: Propagation of genetically altered tumour cells derived from fine-needle aspirates of primary breast carcinoma. Cancer Res. 1998, 58: 5271-5274.PubMed
46.
Fruehauf JP: In vitro assay-assisted treatment selection for women with breast or ovarian cancer. Endocr Relat Cancer. 2002, 9: 171-182.CrossRefPubMed
47.
Ellis RJ, Fabian CJ, Kimler BF, Tawfik O, Mayo MS, Decelis CR, Jewell WR, Connor C, Praeger M, McGinness M, Mehta R, Fruehauf JP: Factors associated with the success of the extreme drug resistance assay in primary breast cancer specimens. Breast Cancer Res Treat. 2002, 71: 95-102. 10.1023/A:1013843912560.CrossRefPubMed
48.
Xu J-M, Song S-T, Tang Z-M, Jiang Z-F, Liu X-Q, Zhang J, Liu X-W: Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. Breast Cancer Res Treat. 1999, 53: 77-85. 10.1023/A:1006122912146.CrossRefPubMed
Metadata
Title
Breast cancer cell lines: friend or foe?
Authors
Sarah E Burdall
Andrew M Hanby
Mark RJ Lansdown
Valerie Speirs
Publication date
01-04-2003
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 2/2003
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr577

Other articles of this Issue 2/2003

Breast Cancer Research 2/2003 Go to the issue

Meeting report

25th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 10–14 December 2002 Update on clinical research

Research article

Waist–hip ratio and breast cancer risk in urbanized Nigerian women

Commentary

Polarity determination in breast tissue: desmosomal adhesion, myoepithelial cells, and laminin 1

Review

Host microenvironment in breast cancer development Inflammatory and immune cells in tumour angiogenesis and arteriogenesis

Research article

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

Article selection

Articles selected from Faculty of 1000 in October 2002
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits